We are live on ! Find out more
FI

Fosun International Portfolio holdings

AUM $399M
1-Year Est. Return 16.11%
This Fund
S&P 500
This Quarter Est. Return
+12.61%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$1.57B
AUM Growth
-$99.9M
Cap. Flow
-$270M
Cap. Flow %
-17.18%
Top 10 Hldgs %
52.85%
Holding
344
New
45
Increased
88
Reduced
69
Closed
37

Sector Composition

Rank Sector Weight
1 Healthcare 37.62%
2 Financials 6.46%
3 Consumer Discretionary 4.13%
4 Industrials 2.9%
5 Communication Services 2.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAVE
276
DELISTED
Spirit Airlines, Inc.
SAVE
$207K 0.01%
4,000
MRSH
277
Marsh
MRSH
$90.7B
$206K 0.01%
+2,220
New +$196K
DOVA
278
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$205K 0.01%
23,088
-238,692
-91% -$1.94M
GD icon
279
General Dynamics
GD
$104B
$204K 0.01%
1,204
-5,384
-82% -$907K
DDD icon
280
3D Systems Corp
DDD
$425M
$171K 0.01%
16,000
GG
281
DELISTED
Goldcorp Inc
GG
$164K 0.01%
14,400
-9,000
-38% -$96.7K
ZIXI
282
DELISTED
Zix Corporation
ZIXI
$113K 0.01%
17,000
EZPW icon
283
Ezcorp Inc
EZPW
$1.84B
$112K 0.01%
12,000
CTG
284
DELISTED
Computer Task Group, Inc.
CTG
$98K 0.01%
+22,844
New +$97K
ATNM icon
285
CALL
Actinium Pharmaceuticals
ATNM
$26.5M
$78K 0.01%
5,628
-1,876
-25% -$30K
AUY
286
DELISTED
Yamana Gold, Inc.
AUY
$44K ﹤0.01%
17,000
CHEKW
287
DELISTED
Check-Cap Ltd. Series A Warrant
CHEKW
$43K ﹤0.01%
333,333
ATNM icon
288
Actinium Pharmaceuticals
ATNM
$26.5M
$26K ﹤0.01%
+1,876
New +$30K
AVDL
289
DELISTED
Avadel Pharmaceuticals
AVDL
$18K ﹤0.01%
11,997
-325,046
-96% -$735K
ADM icon
290
Archer Daniels Midland
ADM
$38.6B
-6,520
Closed -$267K
AIZ icon
291
Assurant
AIZ
$14B
-8,700
Closed -$765K
AJG icon
292
Arthur J. Gallagher & Co
AJG
$65.2B
-12,500
Closed -$904K
BA icon
293
Boeing
BA
$169B
-3,050
Closed -$967K
BFH icon
294
Bread Financial
BFH
$4.37B
-3,884
Closed -$465K
CAH icon
295
Cardinal Health
CAH
$53.6B
-46,081
Closed -$2.06M
CF icon
296
CF Industries
CF
$19.1B
-11,973
Closed -$521K
CIEN icon
297
Ciena
CIEN
$53.9B
-26,500
Closed -$859K
CLSD
298
DELISTED
Clearside Biomedical
CLSD
-10,985
Closed -$178K
CME icon
299
CME Group
CME
$96.6B
-4,600
Closed -$848K
CRTO icon
300
Criteo S.A. Ordinary Shares
CRTO
$1.08B
-672,681
Closed -$15.3M

Similar funds

Fosun International's Q1 2019 Portfolio in Review

As of Q1 2019, Fosun International held 344 positions worth $1.57B, down 6% from $1.67B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Fosun International withdrew a net $270M in Q1 2019, closing 37 positions and reducing 69 holdings. Its most notable exit was iKang Healthcare Group, Inc., an estimated $94.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 39% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Fosun International opened a new position in Baozun worth $20.3M.

  • Fosun International's largest Q1 2019 buy was Baozun: 488,992 shares worth $20.3M.
  • Fosun International added most to Neurocrine Biosciences in Q1 2019, an estimated $3.26M increase.
  • Fosun International's biggest Q1 2019 reduction was Vipshop, cutting an estimated $47.3M.
  • Fosun International fully exited iKang Healthcare Group, Inc. in Q1 2019, selling an estimated $94.3M.
  • Fosun International's ten largest holdings make up 53% of its $1.57B portfolio in Q1 2019.
  • Fosun International opened 45 new positions and closed 37 in Q1 2019.
  • Fosun International's portfolio value fell 6% quarter-over-quarter to $1.57B.

Based on Fosun International's 13F filing for Q1 2019, filed 10 May 2019.